Healthcare data curation and enrichment company Verinovum today announced the launch of its new Data Curation as a Service (DCaaS) solution for payers, providers, healthcare systems, and OEM partners.
Verinovum’s targeted use case modules focus on specific clinical data curation parameters and are custom tailored to provide clients a clear, trusted, comprehensive data curation and enrichment engine required to optimize use case analytics and outcomes. Targeted use cases include chronic care management of conditions such as CHF, COPD, asthma, diabetes, oncology, and others, as well as preventive care efforts such as immunizations, prenatal care, medication management, and more.
“Institutions across the healthcare continuum will get greater benefit out of their disparate data if they approach it from the perspective of targeted use case needs,” says Verinovum CEO Mark McCurry. “Some organizations approach the challenge of disparate data by extracting and dumping data into agnostic groupings. This data then ends up being manually manipulated for a specific use case., which is labor-intensive, rigid, and reactive. Our approach is different; we focus on the highest value data sets within each specific use case, and then curate and enrich them within those parameters to the point of true reliability. This method provides flexibility to meet clients’ top priorities for today, while maintaining flexibility as business, clinical, and legislative stakeholder needs shift over time.”
The importance of these targeted modules arose out of real-world examples derived from Verinovum’s payer, provider, and other healthcare organization clients. For example, if 10% of a payer’s members have diabetes, but curated/enriched A1c lab data only exists on 35% of that population, the payer is missing out on a significant opportunity to enroll two-thirds of its diabetic population into disease management programs that can improve patient outcomes, reduce the risk of acute events, reduce unnecessary hospital admissions and readmissions, and lower downstream healthcare costs. In addition to putting members at risk, the downstream implications on ROI can be significant.